- Quotes
- Dashboard
- Chart
- Historical Prices
- Options
- News & PR
- News
- Market Currents
- Press Releases
- Coverage
- Cramer
- Top Analysts
- Business Intelligence
- Transcripts
- Events
- Key Developments
- Earnings
- History & Projected
- Consensus
- Peer Earnings
- Filings
- SEC Filings
- Annual Report
- Financials
- Income Statement
- Balance Sheet
- Cash Flow
52wk high:
52wk low:
EPS:
PE:
Div Rate:
Yield:
Market Cap:
Volume:
CADX Market Currents
more »
-
February 7 Cadence Pharmaceuticals (CADX +0.1%) voluntarily recalls some of its Ofirmev pain reliever injection vials after an unidentified particle was found in one of the lot's vials during routine stability testing.
Comment![Healthcare]
CADX in Focus
more »
CADX Related Articles
more »
CADX News
more »
-
at MarketWatch.com (Nov 23, 2011)
-
at MarketWatch.com (Mar 4, 2011)
-
at MarketWatch.com (Nov 3, 2010)
-
at MarketWatch.com (Nov 3, 2010)
CADX Press Releases and Filings
more »
-
PR Newswire (May 11, 2012)
-
PR Newswire (May 3, 2012)
-
PR Newswire (May 2, 2012)
-
PR Newswire (Apr 24, 2012)
-
PR Newswire (Mar 12, 2012)
CADX Latest Transcript
more »
-
Fri, Nov 5, 2010
CADX Cramer
more »
Currently, there are no Cramer articles on CADX.
CADX Instablog posts
more »
CADX vs. ETF Alternatives
Company Description
Currently, there's no company description for CADX.